Search Results

Palmitoylethanolamide 200 mg  | 100.00%

TargetMol

Palmitoylethanolamide is an endogenously fatty acid amide. It has a role as an anti-inflammatory drug, an antihypertensive agent, a neuroprotective agent and an anticonvulsant.Upon administration, palmitoylethanolamide may inhibit the release of pro-inflammatory mediators from activated mast cells.

More Information Supplier Page

Palmitoylethanolamide 25 mg  | 100.00%

TargetMol

Palmitoylethanolamide is an endogenously fatty acid amide. It has a role as an anti-inflammatory drug, an antihypertensive agent, a neuroprotective agent and an anticonvulsant.Upon administration, palmitoylethanolamide may inhibit the release of pro-inflammatory mediators from activated mast cells.

More Information Supplier Page

Palmitoylethanolamide 10 mg  | 100.00%

TargetMol

Palmitoylethanolamide is an endogenously fatty acid amide. It has a role as an anti-inflammatory drug, an antihypertensive agent, a neuroprotective agent and an anticonvulsant.Upon administration, palmitoylethanolamide may inhibit the release of pro-inflammatory mediators from activated mast cells.

More Information Supplier Page

ORY1001 50 mg  | 99.96%

TargetMol

ORY-1001 (RG-6016) is an orally active and selective lysine-specific demethylase LSD1/KDM1A inhibitor, with high selectivity against related FAD dependent aminoxidases with IC50 of

More Information Supplier Page

ORY1001 10 mg  | 99.96%

TargetMol

ORY-1001 (RG-6016) is an orally active and selective lysine-specific demethylase LSD1/KDM1A inhibitor, with high selectivity against related FAD dependent aminoxidases with IC50 of

More Information Supplier Page

ORY1001 2 mg  | 99.96%

TargetMol

ORY-1001 (RG-6016) is an orally active and selective lysine-specific demethylase LSD1/KDM1A inhibitor, with high selectivity against related FAD dependent aminoxidases with IC50 of

More Information Supplier Page